Advertisement

Organisation › Details
Gilead Sciences Inc. (Nasdaq: GILD)
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. *
![]() |
Start | 1987-06-22 established |
Group | Gilead Sciences (Group) | |
![]() |
Industry | biopharmaceutical |
Industry 2 | virostatic agent | |
Street | 333 Lakeside Drive | |
City | 94404 Foster City, CA | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 22,449,000,000 (revenues, total, consolidated (2019) 2019-12-31) | |
Profit | 5,364,000,000 (2019-12-31) | |
Cash | 25,840,000,000 (2019-12-31) | |
* Document for �About Section�: | ||
Record changed: 2021-03-26 |
Advertisement

More documents for Gilead Sciences (Group)
- [1] Galapagos N.V.. (2/10/21). "Press Release: Galapagos and Gilead Discontinue ISABELA Phase 3 Trials in IPF". Foster City, CA & Mechelen....
- [2] Gilead Sciences, Inc.. (1/6/21). "Press Release: Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors". Santa Monica, CA, Oxford & San Jose, CA....
- [3] Galapagos N.V.. (12/15/20). "Press Release: Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca (filgotinib)". Foster City, CA & Mechelen....
- [4] Ori Biotech Ltd.. (12/15/20). "Press Release: Ori Biotech Adds to Its World-Class Team". London & Woodcliff Lake, NJ....
- [5] Gilead Sciences, Inc.. (12/10/20). "Press Release: Gilead Sciences to Acquire MYR GmbH". Foster City, CA & Bad Homburg....
- [6] Gilead Sciences, Inc.. (10/23/20). "Press Release: Gilead Sciences Completes Acquisition of Immunomedics, Inc.". Foster City, CA....
- [7] ProteoNic B.V.. (10/20/20). "Press Release: ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics". Leiden....
- [8] Gilead Sciences, Inc.. (9/13/20). "Press Release: Gilead Sciences to Acquire Immunomedics". Foster City, CA & Morris Plains, NJ....
- [9] Galapagos N.V.. (8/19/20). "Press Release: Galapagos Announces that Gilead Received a Complete Response Letter for Filgotinib for the Treatment of Moderately to Severely Active Rheumatoid Arthritis". Mechelen....
- [10] MYR GmbH. (8/4/20). "Press Release: MYR Pharmaceuticals Receives Conditional Marketing Authorization by the European Commission for Hepcludex". Bad Homburg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top